Law firm Cleary buys legal tech company in AI bid
March 17 (Reuters) - Cleary Gottlieb Steen & Hamilton has acquired a legal technology company, a rare move as large law firms race to invest in generative artificial intelligence.
Cleary acquired Springbok AI, a London-founded consultancy and company that develops technology products for lawyers, and that has previously partnered with other law firms. New York-founded Cleary said the addition of Springbok's team will help the firm build its own AI tools.
Springbok and Cleary did not disclose the deal's financial terms.
Artificial intelligence has captured the attention of law firms and the legal industry broadly, with promises to speed up tasks and change the way that lawyers work.
Sixty-three percent of lawyers surveyed by Reuters' parent company Thomson Reuters last year said they have used AI for work, and 12% said they use it regularly. Thomson Reuters also markets AI tools for lawyers.
Cleary managing partner Michael Gerstenzang said in a statement that the deal "immediately enables us to create custom AI-powered solutions — something that sets us apart from many of our competitors."
It is not common for law firms to acquire technology companies, legal industry consultants said, with many instead contracting with outside vendors and working to build their own internal AI capabilities.
"It's extremely rare" for law firms to make technology company acquisitions, said Joe Borstein, a partner at Baretz+Brunelle and co-founder of legal technology accelerator LexFusion. Law firms generally "don't have a vision of what they can do with embedded technology," he said.
Cleary as part of the deal is bringing on Springbok AI's co-founder and CEO Victoria Albrecht and 10 data scientists and AI engineers who will form a new team at the firm.
"We are bypassing the time that it would take to build this team by hand," Ilona Logvinova, director of practice innovation at Cleary, told Reuters.
Legal experts said law firms have faced challenges attracting talent to create their own internal technology tools.
"Building data science and AI teams in law firms is not easy," said Daniel Linna, director of law and technology initiatives at Northwestern University's law and engineering schools.
Logvinova, who joined Cleary about a year ago from McKinsey, said the new team will focus on building AI for the firm's internal use to meet client needs. The firm also has a technology subsidiary, called ClearyX that works on projects directly with clients.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
2 hours ago
- Reuters
Eyekandy Launches Sales Ambassador, World's First Digital Human Super-Salesperson for Every Point of Purchase
LONDON, United Kingdom, June 11, 2025 (EZ Newswire) -- Eyekandy, opens new tab, a global leader in immersive retail commerce, today announced the launch of Sales Ambassador™, the world's first digital human super-salesperson created to transform the shopping experience at every point of purchase. Sales Ambassador is an advanced AI-powered digital human who provides real-time, human-like product guidance for shoppers online, in-store, and on social channels. This isn't just another text based chatbot—the solution delivers visual human-like, always-on support, personalized recommendations, combined with a unique use of augmented reality to showcase products for shoppers, enabling brands and retailers to offer consistent, expert assistance to every customer, anytime and anywhere. With the rapid adoption of AI in retail, Eyekandy's Sales Ambassador addresses two critical challenges facing the industry: driving sales and reducing servicing costs. The digital human never sleeps, never takes breaks, and communicates fluently in more than 20 languages. It analyzes individual shopper needs and delivers tailored product recommendations, helping customers make confident purchase decisions and reducing costly returns. Sales Ambassador integrates effortlessly into existing retail infrastructure, offering plug-and-play deployment for brands and retailers seeking to enhance customer engagement without increasing headcount. 'Sales Ambassador is built to perform better than the best sales rep—24/7,' said Joe Golden, product director of Eyekandy. 'Our technology guides shoppers across web, mobile, social, and even in-store kiosks, driving conversions and providing real-time support at every stage of the buying journey.' The global immersive technology market was valued at $44 billion in 2024 and is projected to reach $184 billion by 2030, growing at a CAGR of over 26%. AI for sales and marketing is anticipated to hit $58 billion by 2025, with more than 70% of U.S. retail executives planning to increase their investment in AI over the next year. Eyekandy's Sales Ambassador is positioned to capitalize on this growth, offering a scalable solution for brands seeking to optimize sales and operational efficiency. 'Imagine deploying your most persuasive and knowledgeable salesperson to every product page, every store aisle, and every shopper's pocket,' added Golden. 'Sales Ambassador does not just sell—it delivers a consistent, personalized experience that builds brand trust and drives measurable results.' Retailers and brands ready to enhance customer confidence, reduce returns, and unlock new sales growth can visit opens new tab to learn more and request a live demonstration, opens new tab. About Eyekandy Eyekandy is a leading provider of immersive commerce solutions, specializing in advanced AI and augmented reality to enhance the shopping experience for consumers and brands. Established in 2016, Eyekandy serves more than 100 retailers and brands across 36 countries, reaching over half a billion unique visitors annually. The company has received multiple innovation awards for its dedication to creativity and excellence in retail technology. For more information, visit Media Contact Angela Platts letstalk@ ### SOURCE: Eyekandy Copyright 2025 EZ Newswire See release on EZ Newswire
Daily Mail
2 hours ago
- Daily Mail
Firm linked to Baroness Bra 'must pay back £122m for faulty PPE': Government suing over Covid contract 'initiated' by Tory peer
A firm linked to Michelle Mone must repay £122million for allegedly breaching a Covid PPE contract, a court heard yesterday. The bra tycoon had recommended PPE Medpro, which went on to provide 25 million 'faulty' surgical gowns. The consortium, led by the Tory peer's husband Doug Barrowman, was awarded contracts by the former Conservative administration during the pandemic. PPE Medpro is now being sued by the Department of Health and Social Care (DHSC), with Government lawyers claiming the gowns couldn't be used because they were not sterile. Baroness Mone and the firm both deny any wrongdoing. The Government is seeking to recover the costs of the contract, plus an additional £8,648,691 for transporting and storing the items. PPE Medpro said it 'categorically denies' breaching the contract, with its lawyers claiming the company has been 'singled out for unfair treatment'. Opening the trial, Paul Stanley KC, for the DHSC, said: 'This case is simply about whether 25 million surgical gowns provided by PPE Medpro were faulty. It is, in short, a technical case about detailed legal and industry standards that apply to sterile gowns.' Mr Stanley said in written submissions the 'initial contact with Medpro came through Baroness Mone', with contract discussions then going through one of the firm's directors, Anthony Page. Baroness Mone remained 'active throughout' negotiations, he said, with the peer stating Mr Barrowman had 'years of experience in manufacturing, procurement and management of supply chains'. But he said Baroness Mone's communications were not part of this case, which was 'simply about compliance'. He added: 'The department does not allege anything improper happened, and we are not concerned with any profits made by anybody.' In court documents from May this year, the DHSC said the gowns were delivered to the UK in 72 lots between August and October 2020, with almost £122million paid to PPE Medpro between July and August that year. The department rejected the gowns in December 2020 and told the firm it would have to repay the money, but this has not happened and the gowns remain in storage. Mr Stanley said 99.9999 per cent of the gowns should have been sterile under the terms of the contract. The DHSC claims the deal also specified PPE Medpro had to sterilise them using a 'validated process', attested by CE marking, which indicates a product has met certain medical standards. He said 'none of those things happened', and that of 140 gowns tested for sterility, 103 failed. He added that the DHSC 'was entitled to reject the gowns, or is entitled to damages, which amount to the full price and storage costs'. Charles Samek KC, for PPE Medpro, said the 'only plausible reason' for the gowns becoming contaminated was due to 'the transport and storage conditions or events to which the gowns were subject' after delivery. He said testing was done several months after the gowns were rejected, and that the samples were not 'representative of the whole population'. Mr Samek described the DHSC's claim as 'contrived and opportunistic', with PPE Medpro 'made the fall guy for a catalogue of failures... and uncontrolled buying spree with taxpayers' money'. Neither Baroness Mone nor Mr Barrowman is due to give evidence during the five-week trial. A PPE Medpro spokesman said it 'categorically denies breaching its obligations' and will 'robustly defend' the claim.
Reuters
3 hours ago
- Reuters
US regulators push through last-minute delay to new private fund reporting rules
NEW YORK, June 11 (Reuters) - U.S. regulators scrambled on Wednesday to extend a deadline for new data reporting requirements for investment advisers to private funds, just one day before they were due to take effect. The rules, adopted by two U.S. markets regulators in February 2024, will require advisers to disclose more information to regulators in a bid to boost the government's ability to spot risks from private markets that have swelled in size in recent years. The U.S. Securities and Exchange Commission extended the deadline for compliance to later this year in a 3-1 vote on Wednesday, less than 24 hours before firms had to comply. The Commodity Futures Trading Commission also voted in favor of an extension, marking the second time the regulators decided to push back the deadline after previously postponing it in January. "Additional time is required for dialogue with filers, review of the reasonableness of the data demands, and review of the actual utility of the information collected," SEC Chairman Paul Atkins said during Wednesday's open meeting. Private funds have pressed the SEC to review this rule, among others, and have warned the new requirements are unnecessary and costly. The firms now have until October 1, 2025 to comply. The new data, which includes disclosure of events pointing to significant stress within 72 hours, would be accessible to the Financial Stability Oversight Council, which gathers top financial regulators across the U.S. government to monitor systemic risks. Regulators have cautioned for years that growing private markets could pose increasing risks, particularly as they are more opaque and less vigorously regulated than traditional markets. Federal agencies have begun a push to loosen regulations as part of Republican President Donald Trump's agenda since he took office in late January. "The SEC and other regulators, including FSOC, depend on these detailed data to better comprehend when the private markets may be experiencing turbulence that could affect our entire financial system, because these entities generally operate outside our regulatory purview," said Caroline Crenshaw, the lone Democratic SEC commissioner.
